EP4356902A1 — A capsule comprising lansoprazole
Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2024-04-24 · 2y expired
What this patent protects
The present invention relates to a pharmaceutical composition in the form of capsule having micro or mini tablet wherein; the tablets comprising a core tablet comprising lansoprazole and an enteric coating comprising at least one enteric coating polymer. The capsules are obtained…
USPTO Abstract
The present invention relates to a pharmaceutical composition in the form of capsule having micro or mini tablet wherein; the tablets comprising a core tablet comprising lansoprazole and an enteric coating comprising at least one enteric coating polymer. The capsules are obtained by a process which is simple, rapid, cost effective, time-saving and industrially convenient process.
Drugs covered by this patent
- Dexilant (DEXLANSOPRAZOLE) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.